• Applied Workflows with HyperScribe SP6 High Yield RNA Synthe

  2026-04-20

  The HyperScribe SP6 High Yield RNA Synthesis Kit delivers rapid, robust, and flexible RNA production for advanced molecular biology needs. Its streamlined SP6 RNA polymerase workflow offers unmatched yields for capped, biotinylated, or radiolabeled RNA, supporting everything from translational research to probe-based assays.

• Z-WEHD-FMK: Optimizing Caspase Pathway Analysis in Research

  2026-04-20

  Z-WEHD-FMK (Z-Trp-Glu(OMe)-His-Asp(OMe)-FMK) empowers researchers to dissect inflammatory and pyroptotic signaling with unmatched specificity and reproducibility. Explore advanced workflows, troubleshooting strategies, and protocol parameters for maximizing impact in inflammation and infectious disease research.

• Dasatinib Monohydrate in Assembloid Models: Next-Gen Kinase

  2026-04-19

  Explore how Dasatinib Monohydrate (BMS-354825) enables advanced, physiologically relevant kinase research in assembloid systems. Discover fresh insights into resistance mechanisms and personalized assay design beyond conventional cell models.

• BX795: Precision PDK1 Inhibitor for Immune and Cancer Assays

  2026-04-18

  BX795 empowers researchers to dissect PI3K/Akt/mTOR signaling and innate immune crosstalk with high selectivity. Its ability to inhibit PDK1, TBK1, and IKKε enables advanced study of cancer cell growth and antiviral mechanisms, as evidenced by recent breakthroughs in hepatitis B research.

• Cx43/NF-κB Pathway Mediates AngII-Induced Macrophage Polariz

  2026-04-17

  This study reveals that angiotensin II drives RAW264.7 macrophages toward a pro-inflammatory M1 phenotype via the connexin 43 (Cx43)/NF-κB signaling axis. Pharmacological blockade of Cx43 hemichannels, including with Gap19, suppresses this polarization, highlighting a mechanistic link relevant for inflammation and atherosclerosis research.

• ML133 HCl: Precision Potassium Channel Inhibitor for Kir2.1

  2026-04-16

  ML133 HCl is a benchmark potassium channel inhibitor, enabling researchers to dissect Kir2.1-mediated events in cardiovascular and pulmonary models with exceptional specificity. Its robust selectivity and compatibility with advanced workflows make it indispensable for translational studies of smooth muscle cell proliferation and vascular remodeling.

• Amitriptyline HCl in Neuropharmacology: Next-Gen BBB Models

  2026-04-15

  Amitriptyline HCl, supplied by APExBIO, empowers high-throughput blood-brain barrier (BBB) modeling and neurotransmitter modulation studies. Leveraging new surrogate barrier models, this article details actionable workflows, troubleshooting strategies, and translational best practices for CNS drug research.

• 17-AAG (Tanespimycin): Advancing HSP90 Inhibition in Oncolog

  2026-04-14

  Explore how 17-AAG (Tanespimycin) redefines HSP90 chaperone inhibition in cancer research. This thought-leadership article blends mechanistic insight—spanning client protein degradation, apoptosis, and pioneering links to DAMP release pathways—with actionable guidance for translational researchers. We contextualize 17-AAG’s role in the competitive landscape, highlight its translational relevance, and chart a forward-looking vision for oncology research, leveraging the latest evidence and APExBIO’s product leadership.

• Tetrahedral DNA Frameworks Enhance Enzymatic DNA Synthesis A

  2026-04-13

  This article reviews a recent study demonstrating that tetrahedral DNA nanostructures (TDN) create an ordered interface for enzymatic oligonucleotide synthesis (EOS), improving enzyme accessibility and synthesis fidelity. The findings offer important advances for DNA data storage and high-fidelity nucleic acid labeling.

• iPSC-Derived Organoids Enable Pan-Tissue Hepatitis E Virus M

  2026-04-12

  This study establishes iPSC-induced multilineage human organoids—liver, intestinal, and brain—as robust in vitro platforms supporting full-cycle propagation of multiple hepatitis E virus (HEV) genotypes. The findings reveal HEV’s broad tissue tropism and provide a physiologically relevant model for virology and antiviral research, significantly advancing the field beyond traditional mono-cellular systems.

• Sequencing Therapies in Waldenström Macroglobulinemia: Role

  2026-04-12

  This article analyzes the key findings from Sarosiek et al. (2021), which addresses the complexities of therapeutic sequencing in Waldenström macroglobulinemia (WM), with an emphasis on the impact of MYD88 and CXCR4 mutations. The discussion highlights how genomic profiling guides treatment selection and explores the emerging role of CXCR4 antagonists such as mavorixafor in clinical research.

• Dihydroartemisinin: Advanced Workflows for mTOR and Malaria

  2026-04-11

  Dihydroartemisinin from APExBIO stands out as a potent Artemisia plant extract, enabling robust assays in cell signaling, malaria, and inflammatory models. This guide delivers protocol enhancements, troubleshooting expertise, and cross-study insights to maximize reproducibility and data clarity for translational research teams.

• Crizotinib Hydrochloride: ALK Kinase Inhibitor in Assembloid

  2026-04-11

  Crizotinib hydrochloride empowers the precise study of ALK and ROS1-driven oncogenic pathways in complex gastric cancer assembloid models. By integrating patient-derived stromal populations, researchers can now uncover resistance mechanisms and optimize personalized drug screening with unprecedented fidelity.

• Gamithromycin: Advanced PK/PD Insights and Site-Specific ...

  2026-04-10

  Explore the advanced pharmacokinetics and site-of-action efficacy of Gamithromycin, a 15-membered semi-synthetic macrolide antibiotic. This article provides an in-depth, evidence-based perspective on tissue-targeted delivery and PK/PD optimization for veterinary respiratory infections, offering unique scientific insights beyond existing protocols.

• Gamithromycin: Applied Protocols for Veterinary Respirato...

  2026-04-09

  Gamithromycin, a 15-membered semi-synthetic macrolide antibiotic, offers unmatched precision in targeting key respiratory pathogens in cattle and pigs. Leveraging advanced PK/PD insights and streamlined workflows, researchers can maximize both bactericidal efficacy and translational relevance, setting a new standard for respiratory disease models.

466 records 22/32 page Previous Next First page 上5页 2122232425 下5页 Last page